Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Computer-aided Drug Discovery Market Anticipated to Garner a Revenue of $7,504.7 Million and Rise at a Noteworthy CAGR of 11.48% over the 2022-2030 Timeframe [240-Pages] | Research Dive

This image opens in the lightbox

News provided by

Research Dive

21 Jun, 2022, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

The global computer-aided drug discovery market is expected to see striking growth by 2030, due to the growing utilization of artificial intelligence in drug discovery. The North America region is expected to hold the largest share of the market.

NEW YORK, June 21, 2022 /PRNewswire/ -- Research Dive has added a new report to its offering titled, 'Computer-aided Drug Discovery Market by Type (Structure-Based Drug Design (SBDD), Ligand-based Drug Design (LBDD), and Sequence-based Approaches), Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, and Others), End-user (Pharmaceutical Companies, Biotechnology Companies, and Research Laboratories) and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022–2030.'

According to the report published by Research Dive, the global computer-aided drug discovery market is anticipated to generate a revenue of $7,504.7 million and grow at a healthy CAGR of 11.48% during the estimated period from 2022 to 2030.

Access an Exclusive PDF Sample of the Computer-aided Drug Discovery Market (Including Tables, TOC, and Figures)

Dynamics of the Computer-aided Drug Discovery Market

The increasing usage of artificial intelligence in drug discovery for chemical synthesis, polypharmacology, drug screening, and studying the three-dimensional structure of molecules, is expected to fortify the growth of the computer-aided drug discovery market over the analysis period. Besides, the increasing demand for high-speed drug development for various chronic development like cancer is further expected to bolster the growth of the market during the forecast period. Moreover, the increasing technological advancements in the field of computer-aided drug discovery and growing research activities to provide accurate results in less time are the factors expected to create expansive growth opportunities for the market. However, the lack of skilled professionals in this field may hinder the growth of the market over the estimated timeframe.

Covid-19 Impact on the Computer-aided Drug Discovery Market

Though the rise of the novel coronavirus has devastated several other industries, the computer-aided drug discovery market has experienced a positive impact during the pandemic period. This is mainly due to the increasing R&D activities among scientists, researchers, and biopharmaceutical companies to control the spread of the deadly virus. This has skyrocketed drug discovery activities all across the globe. In addition, the huge investment made by leading market players for technological development in research and development activities has inclined the growth of the market during the period of crisis.

Specific Requirements on Post COVID-19 Impact on Computer-aided Drug Discovery Market? Connect with an Expert Analyst

Segments of the Computer-aided Drug Discovery Market

The report has divided the market into different segments based on type, therapeutic area, end-user, and region.

  • By type, the structure-based drug design sub-segment is expected to be productive and is projected to generate a revenue of $2,471.3 million during the analysis period. The increasing demand for new drugs for various diseases and increasing technological advancements in drug discovery are expected to boost the growth of the market sub-segment over the estimated timeframe.
  • By therapeutic area, the oncology sub-segment is predicted to be the most profitable and is expected to generate a revenue of $1,826.3 million during the forecast period. The increasing demand for cost-effective, successful, and efficient cancer drugs for the treatment of different types of cancer is expected to uplift the growth of the market sub-segment throughout the analysis period.
  • By end-user, the pharmaceutical companies sub-segment is expected to most lucrative and is projected to garner a revenue of $3,018.9 million over the estimated timeframe. The increasing need for applying different approaches to identify chemical compounds beneficial for human use is expected to augment the growth of the market sub-segment during the forecast period.
  • By region, the North America region of the computer-aided drug discovery market is expected to hold the maximum share of the market and is predicted to generate a revenue of $2,514.1 million during the estimated period and grow at a healthy CAGR of 10.83% during the analysis period. The increasing number of cancer cases in this region and growing research activities in institutes and hospitals using computer-aided drug discovery in the field of cancer is expected to drive the regional growth of the market over the analysis period.

Request for Computer-aided Drug Discovery Market Research Report Customization and Avail Amazing Discount

Key Players of the Computer-aided Drug Discovery Market

The major players of the computer-aided drug discovery market include

  1. Aris Pharmaceuticals, Inc
  2. Charles River Laboratories
  3. Aragon Life Sciences Pvt. Ltd.
  4. Bayer AG
  5. Schrödinger, Inc.
  6. AstraZeneca
  7. Bioduro-Sundia
  8. Albany Molecular Research Inc. (AMRI)
  9. BOCSCI Inc

These players are widely working on the development of new strategies such as product development, mergers, collaborations, mergers, and acquisitions to procure a leading position in the global industry.

For instance, in April 2022, Iktos, a leading drug discovery company specializing in the development of AI solutions applied to chemical research, collaborated with Teijin Pharma, a renowned company that provides comprehensive healthcare services to improve the quality of life. With this collaboration, the companies will focus on the incorporation of AI technology to enhance the speed of the drug design process for small molecule drug discovery.

Further, the report also summarizes other important aspects such as product portfolio, the financial performance of the key players, SWOT analysis, and the latest strategy development.

More about Computer-aided Drug Discovery Market:

  • Computer-aided Drug Discovery: A Quick Look at its Types and Examples
  • What is the need for Computer-aided Drug Discovery in Today's World?
  • Global Computer-aided Drug Discovery Market to Rise at a CAGR of 11.48% and Surpass $7,504.7 Million by 2030, Owing to Increasing Investments in Research Activities for Drug Development

Related Trending Article Links:

  • The global medical waste management market was valued at $9,727.24 million in 2020 and is projected to reach $16,395.80 million by 2028: Grab an PDF Sample
  • The global life science analytics software market is anticipated to garner $13,375.8 million in the 2021–2028 period: Grab an PDF Sample
  • The global patient centric healthcare app market is predicted to garner $3, 85,767.5 million in the 2020–2027 timeframe: Grab an PDF Sample

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
+1-(917)-444-1262 (US)
Toll Free: 1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
Blog: https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

Logo : https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.